Current location - Trademark Inquiry Complete Network - Trademark registration - Company Profile of Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
Company Profile of Guangzhou Baiyunshan Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Pharmaceutical Co., Ltd. was founded in 1973. In November 1992, it was approved by the Guangzhou Municipal People's Government. Five companies including Guangzhou Baiyunshan Pharmaceutical Factory were restructured to establish a joint-stock enterprise in November 1993. As one of the first batch of listed companies in Guangzhou, it was listed on the Shenzhen Stock Exchange and now has a total share capital of 469 million yuan. In 2007, the sales scale reached 3.61 billion yuan, and in 2008, the sales scale exceeded 4 billion yuan. The headquarters of Guangzhou Baiyunshan Pharmaceutical Co., Ltd. is located at the east foot of Baiyun Mountain with lush forests and beautiful scenery. It is a famous garden-style enterprise in my country. The company issued shares and was listed on the Shenzhen Stock Exchange in 1993, making it one of the earliest listed companies in my country. At present, the company has nine pharmaceutical manufacturing companies with total assets of more than 2.5 billion yuan, annual sales revenue of more than 2 billion yuan, and total profits and taxes of nearly 300 million yuan. It is the most powerful large-scale well-known enterprise in my country's pharmaceutical industry. It was ranked first among 78 pharmaceutical listed companies in 2002 by international authoritative organizations in terms of operating conditions, fourth in core competitiveness, and fifth in company value.

The company was approved by the Guangzhou Economic Structural Reform Commission Suigai Guzi [1992] No. 11 in 1992, and was established in five branches including the Guangzhou Baiyunshan Pharmaceutical General Factory under the former Guangzhou Baiyunshan Enterprise Group Co., Ltd. A joint-stock company reorganized and established on the basis of a pharmaceutical factory, and established as a standardized joint-stock enterprise in accordance with Document No. 31 [1992] of the National Restructuring Commission. In 1993, the company was approved by the China Securities Regulatory Commission's Zhengjian Fa Shen Zi (1993) Document No. 31 and the Shenzhen Stock Exchange's Shenzhen Stock Exchange Document No. 265, to issue shares to the public and be listed on the Shenzhen Stock Exchange. The stock code is 000522.